Wisconsin Legislature: DHS 115.04(8)(e)

DHS 115.03 Definitions. In this chapter:

(1) “Congenital disorder” means a disorder present at birth, either inherited or due to an influence occurring during gestation up to birth.

(2) “Department” means the Wisconsin department of health services.

(3) “ICD-10-CM” means the International Classification of Diseases, 10th Revision, Clinical Modification.

(4) “Medical consultant” means a physician licensed to practice medicine or osteopathy under ch. 448, Stats., who has expertise in treatment of one or more of the conditions listed under s. DHS 115.04.

(5) “Metabolic disorder” means a disorder of the chemical processes that take place in the body.

(6) “Screening” means checking each member of a population to identify presumptive medical conditions that indicate that diagnostic testing for congenital or metabolic disorders is needed.

(7) “State laboratory” means the state laboratory of hygiene under s. 36.25 (11), Stats.

History: Cr. Register, May, 1993, No. 449, eff. 6-1-93; correction in (2) made under s. 13.92 (4) (b) 6., Stats., Register January 2009 No. 637; CR 14-074: am. (3) Register July 2015 No. 715, eff. 10-1-15.

DHS 115.04 Congenital disorders. Pursuant to s. 253.13 (1), Stats., blood samples taken from each newborn shall be tested for all of the following conditions:

(1)

(a) Phenylketonuria (PKU), ICD-10-CM-E70.0.

(b) Hyperphenylalaninemia, ICD-10-CM-E70.1.

(2) Galactosemia, ICD-10-CM-E74.21.

(3) Congenital hypothyroidism, ICD-10-CM-E03.1.

(4) Hemoglobinopathies, including all of the following:

(a) Sickle cell disease, ICD-10-CM-D57.1.

(b) Hemoglobin S-beta Thalassemia, ICD-10-CM-D57.40.

(d) Hemoglobin disease other, ICD-10-CM-D58.2.

(5) Biotinidase deficiency, ICD-10-CM-D81.810.

(6) Congenital adrenal hyperplasia, ICD-10-CM-E25.0.

(7) Cystic fibrosis, ICD-10-CM-E84.9.

(8) Fatty acid oxidation disorders, including all of the following:

(a) Medium-chain acyl-CoA dehydrogenase deficiency, ICD-10-CM-E71.311.

(b) Long-chain L-3-Hydroxy acyl-CoA dehydrogenase deficiency, ICD-10-CM-E71.318.

(cm) Carnitine palmitoyltransferase IA deficiency, ICD-10-CM-E71.318.

(d) Carnitine palmitoyltransferase II deficiency, ICD-10-CM-E71.318.

(e) Carnitine-acylcarnitine translocase deficiency, ICD-10-CM-E71.318.

(f) Glutaric acidemia type II, ICD-10-CM-E71.313.

(g) 2, 4-Dienoyl-CoA reductase deficiency, ICD-10-CM-E71.318.

(h) Carnitine uptake defect, ICD-10-CM-E71.41.

(i) Medium/short-chain hydroxy CoA dehydrogenase deficiency, ICD-10-CM-E71.318.

(j) Medium-chain ketoacyl-CoA thiolase deficiency, ICD-10-CM-E71.318.

(9) Maple Syrup Urine Disease, ICD-10-CM-E71.0.

(10) Homocystinuria, ICD-10-CM-E72.11.

(11) Tyrosinemia types I, II, and III, ICD-10-CM-E70.21.

(12) Citrullinemia types I and II, ICD-10-CM-E72.23.

(13) Argininosuccinic acidura, ICD-10-CM-E72.22.

(14) Severe Combined Immunodeficiency and related conditions of immunodeficiency, ICD-10-CM-D81.9.

(15) Organic acidemias, including all of the following:

(a) Glutaric acidemia type I, ICD-10-CM-E72.3.

(b) Propionic acidemia, ICD-10-CM-E71.121.

(d) Isovaleric acidemia, ICD-10-CM-E71.110.

(e) 3-Methylcrotony1-CoA carboxylase deficiency, ICD-10-CM-E71.19.

(f) Multiple carboxylase deficiency, ICD-10-CM-D81.818.

(g) 3-Methylglutaconic aciduria, ICD-10-CM-E71.111.

(h) beta-Ketothiolase deficiency, ICD-10-CM-E71.19.

(i) 2-Methyl-3-hydroxbutyric aciduria, ICD-10-CM-
E71.19.

(j) 3-Hydroxy-3-methylglutaric aciduria, ICD-10-CM-
E71.118.

(15m) Spinal muscular atrophy, ICD-10-CM-G12.9.

(16) Critical congenital heart disease, including all of the following:

(a)

1. Coarctation of the aorta, ICD-10-CM-Q25.1.

2. Atresia of aorta, ICD-10-CM-Q25.2.

3. Stenosis of aorta, ICD-10-CM-Q25.3.

(b)

1. Double outlet right ventricle, ICD-10-CM-Q20.1.

2. Double outlet left ventricle, ICD-10-CM-Q20.2.

(d)

1. Hypoplastic left heart syndrome ICD-10-CM-Q23.4.

2. Congenital mitral stenosis or atresia, ICD-10-CM-Q23.2.

(e)

1. Interrupted aortic arch, ICD-10-CM-Q25.4.

2. Atresia of aorta, ICD-10-CM-Q25.2.

3. Stenosis of aorta, ICD-10-CM-Q25.3.

(f)

1. Pulmonary valve atresia, ICD-10-CM-Q22.0.

2. Other congenital malformations of the pulmonary valve, ICD-10-CM-Q22.3.

3. Atresia of pulmonary artery, ICD-10-CM-Q25.5.

(g) Single ventricle heart disease variants other than HLHS, including all of the following:

1. Hypoplastic right heart syndrome, ICD-10-CM-Q22.6.

2. Other congenital malformations of the tricuspid valve ICD-10-CM-Q22.8.

3. Congenital malformations of the tricuspid valve unspecified, ICD-10-CM-Q22.9.

4. Double inlet ventricle, ICD-10-CM-Q20.4.

(h) Tetralogy of fallot, ICD-10-CM-Q21.3.

(i)

1. Total anomalous pulmonary venous return, ICD-10-CM-Q26.2.

2. Anomalous pulmonary venous connection, unspecified, ICD-10-CM-Q26.4.

3. Partial anomalous pulmonary venous connection, ICD-10-CM-Q26.3.

(j) Transposition of the great vessels, ICD-10-CM-Q20.3.

(k) Tricuspid atresia and stenosis, ICD-10-CM-Q22.4.

(L) Truncus arteriosus, ICD-10-CM-Q20.0.

(17) Pompe Disease, ICD-10-CM-E74.02.

History: Cr. Register, May, 1993, No. 449, eff. 6-1-93; emerg. am. (5) and (6), cr. (7), eff. 1-31-95; correction in (intro.) made under s. 13.93 (2m) (b) 7., Stats., Register, July, 1995, No. 475; am. (5) and (6), cr. (7), Register, July, 1995, No. 475, eff. 8-1-95; am. (intro.) and (1) to (6), cr. (8), Register, December, 1999, No. 528, eff. 1-1-00; emerg. cr. (9) to (13), eff. 10-12-02; CR 02-136: cr. (9) to (13) Register March 2003 No. 567, eff. 4-1-03; emerg. cr. (14), eff. 1-1-08; CR 08-005: cr. (14) Register June 2008 No. 630, eff. 7-1-08; CR 14-074: am. (intro.), cr. (15), (16) Register July 2015 No. 715, eff. 8-1-15, and renum. (1) to (1) (a) and am., cr. (1) (b), am. (2), (3), r. and recr. (4), am. (5) to (7), r. and recr. (8), am. (9) to (14), r. and recr. (15), am. (16) Register July 2015 No. 715, eff. 10-1-15; correction in (15) (g) made under s. 35.17, Stats., Register September 2015 No. 717; EmR1920: emerg. am. (title), (intro.), cr. (8) (cm), (15m), eff. 10-15-19; CR 19-064: am. (title), (intro.), cr. (8) (cm), (15m) Register December 2019 No. 768, eff. 1-1-20; EmR2131: emerg. cr. (17), eff. 1-10-22; CR 21-051: cr. (17) Register May 2022 No. 797, eff. 6-1-22.

DHS 115.05 Laboratory tests.